NIGHTWARE, INC — Department of Defense SBIR Phase I: AF203-CSO1
NIGHTWARE, INC — SBIR Phase I award from Department of Defense.
- Amount
- $49,920
- Agency
- Department of Defense · Air Force
- Program / Phase
- SBIR · Phase I
- Topic
- AF203-CSO1
- Solicitation
- X20.3
- NAICS
- —
- Place of performance
- MN
- Period
- 2021-02-18 → 2021-05-19
Description
The NightWare digital therapeutic is indicated to provide vibrotactile feedback on an Apple Watch based on an analysis of heart rate and motion during sleep, for the temporary improvement of sleep disturbance related to nightmares in adults 22 years or older who suffer from nightmare disorder or have nightmares from post-traumatic stress disorder (PTSD). It is intended for home use.